Assembly Biosciences ASMB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.08M— | —— | -$9.2M+9.8% | -$10.2M-15.6% | -$8.82M+14.7% | ||
| $26K-18.8% | $32K0.0% | $32K0.0% | $32K-3.0% | $33K+3.1% | ||
| $1.12M-23.6% | $1.46M-12.5% | $1.67M+100% | $834K+17.1% | $712K-5.2% | ||
| -$523K-944% | $62K-93.2% | $912K— | $0— | -$0— | ||
| -$42K— | —— | $940K— | —— | $290K— | ||
| -$5.09M-352% | $2.02M— | —— | —— | -$4.56M-317% | ||
| $92K-95.7% | $2.13M+148% | $856K+143% | -$2.01M-287% | $1.08M— | ||
| -$7.83M-9.1% | -$7.17M+27.4% | -$9.88M-2.6% | -$9.63M-2.2% | -$9.42M— | ||
| -$22.1M— | —— | -$15.13M+9.7% | -$16.76M+28.5% | -$23.44M-5,659% | ||
| $19K-20.8% | $24K-42.9% | $42K— | $0— | $0— | ||
| $62.96M+445% | $11.55M-93.6% | $180.93M+934% | $17.51M-11.8% | $19.85M-51.5% | ||
| $57.6M+75.6% | $32.8M+44.5% | $22.7M-34.2% | $34.5M+30.5% | $26.43M-22.7% | ||
| -$5.38M— | —— | -$158.27M-1,031% | $16.99M+158% | $6.59M— | ||
| $0— | —— | —— | —— | $1.92M-5.3% | ||
| $149K-67.3% | $456K-99.7% | $171.93M+48,060% | $357K-81.4% | $1.92M-88.7% | ||
| -$27.33M-176% | $35.92M+2,540% | -$1.47M-348% | $593K+104% | -$14.93M-251% | ||
| —— | $7500.0% | $7500.0% | $7500.0% | $750— | ||
| -$849K— | —— | $1.37M+429% | -$415K-149% | -$167K-124% | ||
| -$202K-3.6% | -$195K+2.5% | -$200K+4.8% | -$210K-43.8% | -$146K+58.6% | ||
| -$5.09M-352% | $2.02M— | —— | —— | -$4.56M-317% | ||
| $92K-95.7% | $2.13M+148% | $856K+143% | -$2.01M-287% | $1.08M— | ||
| $204K0.0% | $204K-2.4% | $209K-4.6% | $219K0.0% | $219K-38.0% | ||
| $57.6M+75.6% | $32.8M+44.5% | $22.7M-34.2% | $34.5M+30.5% | $26.43M-22.7% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $1.38M0.0% | $1.38M0.0% | $1.38M0.0% | $1.38M— | ||
| -$7.83M-9.1% | -$7.17M+27.4% | -$9.88M-2.6% | -$9.63M-2.2% | -$9.42M— | ||
| -$22.12M— | —— | -$15.18M+9.4% | -$16.76M+28.5% | -$23.44M-5,659% | ||
| -$22.12M— | —— | -$15.18M+9.4% | -$16.76M+28.5% | -$23.44M-5,659% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Assembly Biosciences generate?
- Assembly Biosciences (ASMB) generated -$77.4M in operating cash flow over the trailing twelve months.
- What is Assembly Biosciences's free cash flow?
- After $85.0K of capital expenditures, Assembly Biosciences's free cash flow was -$77.5M over the trailing twelve months, down 51.5% year over year.
- Where does Assembly Biosciences's cash flow data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
